TRIM21 promotes ubiquitination of SARS-CoV-2 nucleocapsid protein to regulate innate immunity

J Med Virol. 2023 Apr;95(4):e28719. doi: 10.1002/jmv.28719.

Abstract

The innate immune response is the first line of host defense against viral infections, but its role in immunity against SARS-CoV-2 remains unclear. By using immunoprecipitation coupled with mass spectroscopy, we observed that the E3 ubiquitin ligase TRIM21 interacted with the SARS-CoV-2 nucleocapsid (N) protein and ubiquitinated it at Lys375 . Upon determining the topology of the TRIM21-mediated polyubiquitination chain on N protein, we then found that polyubiquitination led to tagging of the N protein for degradation by the host cell proteasome. Furthermore, TRIM21 also ubiquitinated the N proteins of SARS-CoV-2 variants of concern, including Alpha, Beta, Gamma, Delta, and Omicron together with SARS-CoV and MERS-CoV variants. Herein, we propose that ubiquitylation and degradation of the SARS-CoV-2 N protein inhibited SARS-CoV-2 viral particle assembly, by which it probably involved in preventing cytokine storm. Eventually, our study has fully revealed the association between the host innate immune system and SARS-CoV-2 N protein, which may aid in developing novel SARS-CoV-2 treatment strategies.

Keywords: SARS-CoV-2; TRIM21; innate immunity; nucleocapsid; ubiquitination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Coronavirus Nucleocapsid Proteins / metabolism
  • Humans
  • Immunity, Innate
  • SARS-CoV-2* / metabolism
  • Ubiquitin / metabolism
  • Ubiquitination

Substances

  • Ubiquitin
  • Coronavirus Nucleocapsid Proteins
  • SS-A antigen

Supplementary concepts

  • SARS-CoV-2 variants